$VICR

Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday - Intel (NASDAQ:INT

Vicor Corp (VICR) shares rose 13.5% to $208.73 after granting a license for its patents. Other stocks gaining include Securitize (SECZ) +21%, Generac (GNRC) +19.6%, and Arm (ARM) +6.7%. Generac's rise follows a supply deal with Amazon and a price target increase. Micron (MU) gained 5.6% amid a memory stock rally.

Original reporting
Published Sep 17, 2026, 3:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 4:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$VICR
Bullish
medium confidence
Mentioned
$VICR · $SECZ · $GNRC · $ABSI · $SDGR · $TEM
Relevance
4/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$VICRBullishLow
01

Why it matters

The article aggregates fresh, company‑specific news (e.g., Vicor license, Generac‑Amazon deal, Twist‑Lilly partnership) alongside broader sector momentum, offering limited actionable insight.

02

Market read

Highlights a broad tech rally with several companies receiving fresh catalysts, but overall article serves as a summary rather than deep analysis.

03

What to watch

Potential profit‑taking and lack of deep catalysts for several listed stocks.

Relevance 4/10Novelty 3/10Timing: today

Background

Market wrap summarizing top‑gaining U.S. stocks on a strong Nasdaq day.

Company-level read

Ticker impact

$VICRBullishMedium confidence
Context

Vicor announced a non‑exclusive license to a new OEM, driving a 13.5% jump.

Expected impact

short‑term upside as investors price new licensing revenue.

Evidence & confidence

First report of the license; market reacted strongly.

$SECZBullishLow confidence
Context

Securitize shares rose 21% after unspecified news, listed as a top mover.

Expected impact

potential continuation if catalyst confirmed.

Evidence & confidence

Article provides no detail beyond the move.

$GNRCBullishMedium confidence
Context

Generac secured a long‑term supply agreement with Amazon for data‑center generators.

Expected impact

mid‑term upside as contract ramps.

Evidence & confidence

First disclosure of the Amazon agreement.

$ABSINeutralLow confidence
Context

Absci shares gained 18.8% with no specific catalyst disclosed.

Expected impact

uncertain without clear news.

Evidence & confidence

Article lacks concrete detail.

$SDGRNeutralLow confidence
Context

Schrödinger reported inducement grants under Nasdaq Listing Rule 5635(c)(4).

Expected impact

limited impact.

Evidence & confidence

Regulatory notice only.

$TEMNeutralLow confidence
Context

Tempus AI shares rose 14.7% with no detailed catalyst provided.

Expected impact

no clear direction.

Evidence & confidence

No specific news disclosed.

$PSIXNeutralLow confidence
Context

Power Solutions International rose 14.1% with no explicit reason given.

Expected impact

uncertain.

Evidence & confidence

Lack of concrete catalyst.

$RXTNeutralLow confidence
Context

Rackspace Technology gained 14% in the session.

Expected impact

no specific outlook.

Evidence & confidence

No company‑specific news.

Market effects

Broad tech and semiconductor rally lifts multiple names.

U.S. equity markets gain momentum.

Highlights continued AI‑driven enthusiasm worldwide.

Counterpoint

Many moves may be short‑term momentum without lasting fundamentals.

Key entities

  • Vicor Corp

    Announced OEM licensing deal

  • Generac Holdings

    Long‑term supply agreement with Amazon

  • Arm Holdings

    CEO comments on AI demand

  • Twist Bioscience

    Collaboration with Lilly TuneLab

Related articles

$MRNAMedAI 8/10

Moderna jumps nearly 7% ahead of Nasdaq 100 inclusion; Citi warns of 'sell'

Moderna's shares rose 6.95% to $203.21 ahead of its inclusion in the Nasdaq 100. The Nasdaq 100 tracks 100 large non-financial companies, with over $800 billion in assets under management. Citi downgraded Moderna to 'sell' with a $80 target price, citing high market expectations for its cancer pipeline. Moderna's market cap is about $75 billion, and its tokenized shares also increased.

$TSMMed

Elon Musk hints semiconductor giant could join Texas Terafab chip project

Elon Musk suggested that Taiwan Semiconductor Manufacturing Co. (TSMC) may join Tesla and SpaceX's Terafab chip project in Texas. TSMC shares briefly rose to an all-time high, while Intel shares fell. TSMC is considering a new Texas campus, which could bolster its global operations and support the state's semiconductor sector. TSMC's revenue for January-August 2026 was $106.5 billion, up 39.3% year-over-year, but the company has warned of potential impacts from the Iran war.

$TSMMed

Elon Musk says Terafab is weighing another partner besides Intel

Elon Musk hinted at potential discussions with TSMC to join Tesla and SpaceX's Terafab project, causing TSMC shares to rise before slipping. Intel, a current partner, saw a decline. TSMC's possible expansion in Texas could bolster its global footprint, with strong revenue growth reported. The semiconductor industry in Texas is growing, with significant investments and exports.

$MUHigh

Why 1 Veteran Analyst Says Micron Stock Could Nearly Double Soon

Susquehanna maintained a Positive rating on Micron Technology (MU) with a $2,000 price target, citing stronger memory demand, limited industry investment, and improving earnings prospects. The firm expects fiscal 2027 EPS to reach $176.39 and revenue to hit $284.56 billion, driven by AI demand for high-bandwidth memory. Micron's gross margin is expected to weaken in the November quarter before improving later, with tight supply-demand balance through 2028.